Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial-Reference-Cited by-同舟云学术

Tolerability and Clinical Activity of Post-Transplantation Azacitidine in Patients Allografted for Acute Myeloid Leukemia Treated on the RICAZA Trial

Published:2016-02 Issue:2 Volume:22 Page:385-390
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Craddock Charles^ORCID,Jilani Nadira,Siddique Shamyla,Yap Christina,Khan Josephine,Nagra Sandeep,Ward Janice,Ferguson Paul,Hazlewood Peter,Buka Richard,Vyas Paresh,Goodyear Oliver,Tholouli Eleni,Crawley Charles,Russell Nigel,Byrne Jenny,Malladi Ram,Snowden John,Dennis Mike

Funder

Leukaemia and Lymphoma Research

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach;Cornelissen;Nat Rev Clin Oncol,2012

2. Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors;Hegenbart;J Clin Oncol,2006

3. Hematopoietic-cell transplantation at 50;Appelbaum;N Engl J Med,2007

4. Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia;Tauro;J Clin Oncol,2005

5. Optimising the conditioning regimen for acute myeloid leukaemia;Appelbaum;Best Pract Res Clin Haematol,2009

Cited by 158 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance Therapy for Acute Myeloblastic Leukemia;Advances in Hematological Malignancies [Working Title];2024-08-20

2. Multiple small‐dose infusions of G‐CSF‐mobilized haploidentical lymphocytes after autologous haematopoietic stem cell transplantation for acute myeloid leukaemia;British Journal of Haematology;2024-07-07

3. Azacitidine and gemtuzumab ozogamicin as post-transplant maintenance therapy for high-risk hematologic malignancies;Bone Marrow Transplantation;2024-05-23

4. Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome–A propensity score matched analysis;Hematology, Transfusion and Cell Therapy;2024-05

5. Transplant Eligible and Ineligible Elderly Patients with AML—A Genomic Approach and Next Generation Questions;Biomedicines;2024-04-29